XML 158 R135.htm IDEA: XBRL DOCUMENT v3.24.0.1
Schedule I - Condensed Financial Information of Registrant (Condensed Statements of Cash Flows) (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows — operating activities:      
Cash used in operating activities $ 5,453 $ 485 $ (206)
Cash flows — investing activities:      
Capital expenditures (1,676) (1,301) (1,033)
Cash used in investing activities (2,145) (1,239) (1,153)
Cash flows — financing activities:      
Issuances of preferred stock 0 0 2,000
Stock repurchases (1,245) (1,949) (471)
Dividends paid to common stockholders (313) (302) (290)
Dividends paid to preferred stockholders (150) (151) 0
Other, net 83 31 (21)
Cash provided by (used in) financing activities (294) (80) 2,274
Cash, cash equivalents and restricted cash — beginning balance 525 1,359 444
Cash, cash equivalents and restricted cash — ending balance 3,539 525 1,359
Parent      
Cash flows — operating activities:      
Cash used in operating activities (31) (27) (38)
Cash flows — investing activities:      
Capital expenditures 0 0 0
Dividend received from subsidiaries 1,625 1,775 405
Equity contribution to subsidiaries 0 0 (988)
Cash used in investing activities 1,625 1,775 (583)
Cash flows — financing activities:      
Issuances of preferred stock 0 0 2,000
Stock repurchases (1,245) (1,949) (471)
Dividends paid to common stockholders (313) (302) (290)
Dividends paid to preferred stockholders (150) (151) 0
Other, net 91 40 (23)
Cash provided by (used in) financing activities (1,617) (2,362) 1,216
Net change in cash, cash equivalents and restricted cash (23) (614) 595
Cash, cash equivalents and restricted cash — beginning balance 54 668 73
Cash, cash equivalents and restricted cash — ending balance $ 31 $ 54 $ 668